Stocks / ACRS vs AHCO

Aclaris Therapeutics, Inc. (ACRS) vs AdaptHealth Corp. (AHCO)

Aclaris Therapeutics, Inc. and AdaptHealth Corp. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

AHCO is the larger company ($1.4B vs $0.6B). On the fundamentals, AHCO grows revenue faster (25.2% vs 3.8%); AHCO earns a higher net margin (-2.2% vs -829.6%); AHCO has the stronger return on equity (-4.7% vs -63.0%). Over the last five years, AHCO returned -63.6% vs -75.6%. On the filings, AHCO carries fewer potential red flags (1 vs 2). Full numbers below — the stronger figure on each row is in green.

AI verdict — ACRS vs AHCO, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 Aclaris Therapeutics, Inc. (ACRS)AdaptHealth Corp. (AHCO)
Market cap$0.6B$1.4B
Revenue (latest FY)$7.83M$3.24B
Net income (latest FY)$-64.92M$-70.79M
Revenue growth (5y CAGR)3.8%25.2%
Net margin-829.6%-2.2%
Return on equity-63.0%-4.7%
P/E ratio
Dividend yield
Profitable years (of last 10)04
Positive free cash flowNoYes

Performance — ACRS vs AHCO

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 Aclaris Therapeutics, Inc. (ACRS)AdaptHealth Corp. (AHCO)
1-year return202.1%5.7%
3-year return-58.6%-18.1%
5-year return-75.6%-63.6%
10-year return-76.8%
52-week range$1.34–$5.15$8.06–$13.43

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full ACRS vs AHCO breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open ACRS's full financials →   Open AHCO's full financials →

More comparisons

Frequently asked questions

Which is bigger, ACRS or AHCO?

AdaptHealth Corp. is larger by market capitalization — $1.4B versus $0.6B.

Which grows faster, ACRS or AHCO?

Over the last five fiscal years, AdaptHealth Corp. grew revenue faster — 25.2%/yr versus 3.8%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

ACRS fundamentals → · AHCO fundamentals → · All 1,500+ companies → · Free screener →